From CBC News: A McMaster University committee has been assigned to develop new opioid-prescribing guidelines for Canada’s doctors. While the rules explicitly prohibited anyone with ties to the pharmaceutical industry from sitting on the voting committee, it was recently discovered that one of the committee members had ties to drug companies that sell opioids, revealing the prevalence of financial relationships between doctors, hospitals, and the pharmaceutical industry.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.